Drugs in Dev.
Dermatology
Preclinical
Germany 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Staphylococcus Epidermidis Strain
Therapeutic Area : Dermatology
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Based on the results of the research partnership, Bayer plans to develop selected Staphylococcus epidermidis strains into new natural skin care products under a future License Agreement.
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
January 10, 2020
Lead Product(s) : Staphylococcus Epidermidis Strain
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
